A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With a Focus on Small Cell Lung Cancer and Other Cancers of Neuroendocrine Origin
Phase of Trial: Phase I
Latest Information Update: 24 Oct 2017
At a glance
- Drugs Belinostat (Primary) ; Cisplatin; Etoposide
- Indications Carcinoma; Small cell lung cancer; Solid tumours
- Focus Adverse reactions
- 17 Jun 2017 Status changed from suspended to completed.
- 22 Jul 2016 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.
- 22 Jul 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.